Vincent Pham to Present Huang Lab Research at AACR Annual Meeting 2025
SAN ANTONIO, Texas — The Huang Lab at the Mays Cancer Center at UT Health San Antonio announces that Vincent Pham, Cancer Biology PhD Candidate, will present new preclinical findings at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, Illinois. Dr. Gang Huang, principal investigator, will attend the meeting alongside Vincent.
Vincent will share data on PH102, a GPC3‑targeted CAR T‑cell therapy for hepatocellular carcinoma. The presentation highlights strategies to overcome solid‑tumor resistance and to improve T‑cell function in the tumor microenvironment.
“Our team is advancing cell therapies that address the toughest barriers in liver cancer,” said Dr. Huang. “This work reflects rigorous science and a clear path toward first‑in‑human studies.”
“It is an honor to present at AACR,” said Vincent. “We are excited to discuss our results with the cancer research community and gather feedback that will guide the next studies.”
Presentation details: Session “CAR Therapies: Emerging Approaches and Combinations,” Tuesday, April 29, 2025, 2:00–5:00 PM, Poster Section 38, Poster Board 20, Poster 6112. Conference organizers will provide a poster hall map on site.
About the Huang Lab
The Huang Lab at UT Health San Antonio is a basic and translational cancer research group within the MD Anderson Mays Cancer Center at UT Health San Antonio. Our team integrates hematology and solid tumor biology with immunology and metabolism to uncover mechanisms and design interventions. We advance cell and biologic therapies, including CAR T‑cell approaches for solid tumors. We also conduct research in trauma and military health. We move discoveries toward clinical impact through product development and collaborations with clinicians and industry. Education and mentorship are core to our mission. We train students, postdoctoral fellows, and early‑career scientists in rigorous, multidisciplinary research. Together, we aim to deliver therapies and technologies that improve patient outcomes.